Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2-[(1R)-1-[2-[4-methoxy-3-(2-morpholin-4-ylethoxy)phenyl]-5-methyl-1,3-thiazol-4-yl]ethyl]sulfanyl | 2107280-55-5 | MFCD34469884 | 99.5% | C23H30N6O3S2 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13314110MG

Encompass_Preferred

DI-87 is an orally active, selective deoxycytidine kinase (dCK) inhibitor developed for anticancer research. It exhibits potent biochemical activity in the low-nanomolar range and has demonstrated antitumor effects in preclinical models, where it is used to enhance the efficacy of nucleoside analog therapies.

  • Potent dCK inhibition with low-nanomolar EC50.
  • Orally bioavailable and metabolically stable for in vivo studies.
  • Demonstrated antitumor activity in preclinical tumor models.
  • Enhances efficacy of nucleoside analog therapies in combination studies.
  • Supplied as a stable powder, soluble in DMSO for assay preparation.

Catalog No. 50-002-58317


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.